Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease. Tsai FP, Su TH, Huang SC, Tseng TC, et al. Cancer 2024 Sep 6. doi: 10.1002/cncr.35541.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tsai FP, Su TH, Huang SC, Tseng TC, et al. Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease. Cancer 2024 Sep 6. doi: 10.1002/cncr.35541.
PMID: 39238423